Business Wire CSR | Business Wire | PR NewsWire | Marketwire | Realwire | ACN/JCN newswire | 247pressrelease | PRWeb | EmailWire | 3BLMedia | 1888PressRelease

Strategic Alliance Between Televisa and Genomma Lab

Posted : Mon, 31 Aug 2009 00:03:15 GMT
Author : Genomma Lab Internacional, S.A.B. de C.V.
Category : Press Release
News Alerts by Email ( click here )
News | Home
MEXICO CITY, Aug. 30 Televisa-Genomma-Lab

MEXICO CITY, Aug. 30 /PRNewswire/ -- Grupo Televisa, S.A.B. ("Televisa"; NYSE: TV; BMV: TLEVISA CPO) and Genomma Lab Internacional, S.A.B. de C.V. ("Genomma Lab"; BMV: LAB B) announced today that they have signed a strategic alliance agreement to sell and distribute personal care and over the counter pharmaceuticals in the United States and Puerto Rico.

The strategic alliance will operate through Televisa Consumer Products USA ("TCP") a company owned 51% by Televisa and 49% by Genomma Lab. The sale and distribution of Genomma Lab's products will be an integral part of the activities of TCP.

As part of this alliance, TCP will enter into, among others, a product supply agreement with Genomma Lab. Televisa will make available its different media platforms in the United States and Puerto Rico to TCP, which will provide Genomma Lab's brands with significant advertising in the targeted markets in line with Genomma Lab's business model.

This will enable Genomma Lab to expand the extensive success of its brands beyond Mexico and Latin America by accessing a Hispanic market of approximately 50 million consumers with a purchasing power of over $870 billion annually while leveraging off of Televisa's reach and name recognition in the Hispanic market.

Subject to certain conditions, the parties contemplate closing the transaction in the following months and launching operations by year end.

About Grupo Televisa, S.A.B

Grupo Televisa, S.A.B., is the largest media company in the Spanish-speaking world and a major participant in the international entertainment business. It has interests in television production and broadcasting, production of pay-television networks, international distribution of television programming, direct to home satellite services, cable television and telecommunication services, magazine publishing and publishing distribution, radio production and broadcasting, professional sports and live entertainment, feature-film production and distribution, the operation of an internet portal, and gaming. Grupo Televisa also owns an unconsolidated equity stake in La Sexta, a free-to-air television venture in Spain.

About Genomma Lab Internacional, S.A.B. de C.V.

Genomma Lab Internacional, S.A.B. de C.V. is one of the fastest growing pharmaceutical and personal care products companies in Mexico and has an increasing presence in the international markets. Genomma Lab develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share. The Company has significantly grown its revenue and profitability through a combination of a successful new product development process, consumer-oriented marketing, a broad retail distribution network and a low-cost, highly flexible operating model.

SOURCE Genomma Lab Internacional, S.A.B. de C.V.


Copyright © 2010 PR Newswire. All rights reserved.

Share/Save/Bookmark

Article : Strategic Alliance Between Televisa and Genomma Lab
Print this article
Share this article

Stay Updated

News gadget on your Google homepage
Subscribe to a news feed in Google Reader



Related News



Have your Say
Name
Email
Subject
Your Comment

Enter Verification code
 
  

 
Follow The Earth Times
Subscribe to RSS Follow Earth Times on TwitterNews by email
Share/Save/Bookmark
 
 



 
Subscribe to free Earthtimes
News Alerts by Email Click here
For RSS Feeds Click here
or Create your own RSS

Add to Google Toolbar
Breaking News
Press Releases

 
 

The Earth Times
News Category

© 2010 www.earthtimes.org, The Earth Times, All Rights Reserved | Privacy Policy
Earth Times accept no responsibility or liability either directly or indirectly for views or opinions expressed in articles or comments.